Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association.
about
Prevention, Detection and Management of Coronary Artery Disease in Minority FemalesSolid tumor second primary neoplasms: who is at risk, what can we do?Comparison of relative and attributable risk of myocardial infarction and stroke according to C-reactive protein and low-density lipoprotein cholesterol levelsMultivariate risk assessment and risk score cards in hypertensionABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bileMeasuring allostatic load in the workforce: a systematic reviewHypertension-Related Morbidity and Mortality in African Americans?Why We Need to Do BetterCommunity cardiovascular disease risk from cross-sectional general practice clinical data: a spatial analysis.New Indices of Endothelial Function Measured by Digital Thermal Monitoring of Vascular Reactivity: Data from 6084 Patients Registry.The effects of second-hand smoke on biological processes important in atherogenesis.Factors associated with hypertension prevalence, unawareness and treatment among Costa Rican elderly.An epistemic community comes and goes? Local and national expressions of heart health promotion in CanadaVisualization of coronary wall atherosclerosis in asymptomatic subjects and patients with coronary artery disease using magnetic resonance imaging.Smoking and socio-demographic determinant of cardiovascular diseases among males 45+ years in IndonesiaA single nucleotide polymorphism in the stromal cell-derived factor 1 gene is associated with coronary heart disease in Chinese patients.Prevention of heart disease in women: recommendations for management of risk factors.Evaluation of cardiovascular risk in blood donors: results of the CARDIORISK study in the Parma Transfusion Service.Beyond cholesterol lowering: deciphering the benefits of dietary intervention on cardiovascular diseases.Risk Factor Scenario in an Industrial Set-up: Need for an Effective Screening Tool to Assess the High-Risk Group.Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland.Polymorphisms of methylenetetrahydrofolate reductase gene as the genetic predispositions of coronary artery diseases in eastern India.Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the Translating Research into Action for Diabetes (TRIAD) study.Framingham risk score is associated with femoral artery intima-media thickness in asymptomatic young adults (the Bogalusa heart study).Left atrial volume index and prediction of events in acute coronary syndrome: Solar Registry.Self-reported diagnosis of heart disease: results from the SHIELD study.Impact of Framingham risk score, flow-mediated dilation, pulse wave velocity, and biomarkers for cardiovascular events in stable anginaRelationship between cardiovascular disease knowledge and race/ethnicity, education, and weight status.Framingham Coronary Heart Disease Risk Score Can be Predicted from Structural Brain Images in Elderly Subjects.Reducing global risk for cardiovascular disease: using lifestyle changes and pharmacotherapy.Smoking prevalance and the degree of nicotine dependence among healthcare workers at the ataturk university medical facility.Impact of cardiovascular calcifications on the detrimental effect of continued smoking on cardiovascular risk in male lung cancer screening participants.Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trialIschemic cardiomyopathy is associated with coronary plaque progression and higher event rate in patients after cardiac transplantationThe DHHS Office on Women's Health Initiative to Improve Women's Heart Health: focus on knowledge and awareness among women with cardiometabolic risk factors.Smoking effect on ischemic heart disease in young patientsKnowledge of heart disease risk factors among workers in a Nigerian University: A call for concernAn adaptation of the Framingham coronary heart disease risk function to European Mediterranean areasWorksite Opportunities for Wellness (WOW): effects on cardiovascular disease risk factors after 1 year.Cardiovascular disease risk factors and DNA methylation at the LINE-1 repeat region in peripheral blood from Samoan Islanders.Prevention of cardiovascular diseases: focus on modifiable cardiovascular risk
P2860
Q26775494-E6074269-4789-4750-803F-1C6CE82F7D7FQ27026266-5E67AA37-13A7-4746-B4C4-7918BD027A07Q28212874-C3831A81-A368-46AC-B459-03E235555456Q28219606-4A316BC7-2D63-4862-AEA3-CCD7BC679BA6Q28254190-4EF295D5-8F77-477D-A18C-5F07FCA071B4Q28387999-46882E0D-11EE-463D-B89B-8DFF1C1F2EE3Q29399489-A326737B-8175-494D-8778-582B67B8AD43Q30900391-3E9B8404-7A50-43EA-808E-6131038CB960Q31141689-88CAB546-69C3-4987-BEBE-CC758159A6E5Q33268546-39D25438-1431-4079-8BFC-452CFC0DC882Q33357918-3D495E67-4DDB-4C9D-B0F2-C88C2F2F25CBQ33411547-7B35F6D7-2DB7-42DD-AAC1-8A21F00EF0B8Q33712037-B5A08531-E010-4716-952F-A20CA254C33AQ33893804-EAC76414-339E-4A48-BF5D-29861D761049Q33907969-66D0A744-9617-43A4-9121-552EF9E62627Q33914773-9FF39BBA-AD21-4DE8-A32C-570C6C10E161Q34003468-546E6A3B-AD31-4ADE-B44C-514E8D259C9BQ34107570-577BEB12-4C1A-4B55-AF4A-59A20EF1124EQ34131039-224421EB-2740-4356-BC1D-7B4DA91F8130Q34144326-3E69EA12-FB70-46C7-A8BE-4FFE2DBE7F06Q34313930-4BCB407C-A3B2-4823-9B09-D7F175596626Q34331209-BF240E85-F64F-402F-8B64-B18CDC5B0177Q34384461-E20AC46C-903B-4D1D-93E4-59B09014FE41Q34387819-4DD43297-7E8F-4148-8642-AAE6D8DBB5F8Q34406740-7A4DD27F-CB9B-4AD4-B340-833B9724C59DQ34429549-CE232ECA-D972-43AC-8CBB-745CA5A27591Q34470270-D80FFB81-666C-4757-9A20-4410F0693387Q34597077-D531C100-21D5-4A15-89F6-65F2D97E4FAEQ34645011-734D3277-BD0A-4651-BA28-42345DBE1A26Q34666451-FF20BD71-DDB3-4FF6-9AAB-F393BDE0439BQ34805564-751AE1F4-E75A-485A-B855-33AE19A80B5FQ35016310-EC7D0109-CB58-4F48-A235-01F82406BB3DQ35026402-389D640C-BE63-431A-BA09-0DED6E6AFF30Q35040408-F43EC757-DEA4-48A8-9EBB-86BBFEBF3150Q35069077-5C68825C-F168-4D26-BA75-1BB54C7E0289Q35244606-5C961782-D16B-47C1-9014-CE7EDF454552Q35412825-5B6913DD-182A-4FC5-AEF6-4212D4A2E34EQ35443970-0A705534-D793-41F3-AB85-A62C6A7DFCE6Q35578014-CA4C19E3-ADEE-4F1A-AD0E-C7E69BADF9B5Q35770938-A7427673-C0C5-4491-BEE2-00B465CB9BF8
P2860
Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Primary prevention of coronary ...... n. American Heart Association.
@ast
Primary prevention of coronary ...... n. American Heart Association.
@en
Primary prevention of coronary ...... n. American Heart Association.
@nl
type
label
Primary prevention of coronary ...... n. American Heart Association.
@ast
Primary prevention of coronary ...... n. American Heart Association.
@en
Primary prevention of coronary ...... n. American Heart Association.
@nl
prefLabel
Primary prevention of coronary ...... n. American Heart Association.
@ast
Primary prevention of coronary ...... n. American Heart Association.
@en
Primary prevention of coronary ...... n. American Heart Association.
@nl
P2093
P1433
P1476
Primary prevention of coronary ...... n. American Heart Association.
@en
P2093
Fletcher G
Greenland P
Hiratzka LF
Houston-Miller N
Kris-Etherton P
Krumholz HM
P304
P356
10.1161/01.CIR.97.18.1876
P407
P577
1998-05-01T00:00:00Z